Ultra Curto (Ultra Short) TB Prevention Therapy
NCT04703075
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
531
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis
Interventions
DRUG:
Rifapentine 600 mg and INH 300 mg
DRUG:
Rifapentine 900 mg and INH 900 mg
Sponsor
Johns Hopkins University
Collaborators
[object Object]
[object Object]